Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
4,191
archived clinical trials in
Constipation

Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Houston, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Houston, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Houston, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Longview, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Longview, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
San Antonio, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
San Antonio, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
San Antonio, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
San Antonio, TX
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
San Antonio, TX
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Logan, UT
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Logan, UT
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
South Ogden, UT
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
South Ogden, UT
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Christiansburg, VA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Christiansburg, VA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
Lynchburg, VA
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
Lynchburg, VA
Click here to add this to my saved trials
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated:  2/11/2016
mi
from
La Crosse, WI
Trial of Linaclotide in Patients With Chronic Idiopathic Constipation
A Phase 3, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial of Linaclotide (72 ug or 145 ug) Administered Orally for 12 Weeks to Patients With Chronic Idiopathic Constipation
Status: Enrolling
Updated: 2/11/2016
Ironwood Investigational Site
mi
from
La Crosse, WI
Click here to add this to my saved trials
Safety and Health Intervention Project
Developing a Prescription Opioid Overdose Prevention Intervention in Addictions Treatment
Status: Enrolling
Updated:  2/13/2016
mi
from
Waterford, MI
Safety and Health Intervention Project
Developing a Prescription Opioid Overdose Prevention Intervention in Addictions Treatment
Status: Enrolling
Updated: 2/13/2016
Community Programs, INC.
mi
from
Waterford, MI
Click here to add this to my saved trials
The Effectiveness of Lubiprostone in Constipated Diabetics
A Randomized, Double Blind, Placebo-controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients
Status: Enrolling
Updated:  2/17/2016
mi
from
Atlanta, GA
The Effectiveness of Lubiprostone in Constipated Diabetics
A Randomized, Double Blind, Placebo-controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients
Status: Enrolling
Updated: 2/17/2016
Atlanta Veterans Administration Hospital
mi
from
Atlanta, GA
Click here to add this to my saved trials
The Effectiveness of Lubiprostone in Constipated Diabetics
A Randomized, Double Blind, Placebo-controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients
Status: Enrolling
Updated:  2/17/2016
mi
from
Atlanta, GA
The Effectiveness of Lubiprostone in Constipated Diabetics
A Randomized, Double Blind, Placebo-controlled Trial to Examine the Effectiveness of Lubiprostone on Constipation Symptoms and Colon Transit Time in Diabetic Patients
Status: Enrolling
Updated: 2/17/2016
The Emory Clinic
mi
from
Atlanta, GA
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Oro Valley, AZ
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Harmony Clinical Research
mi
from
Oro Valley, AZ
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Phoenix, AZ
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Central Phoenix Medical Clinic
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Tucson, AZ
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Adobe Gastroenterology, PC
mi
from
Tucson, AZ
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Buena Park, CA
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Associated Pharmaceutical Research Center Inc
mi
from
Buena Park, CA
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Boca Raton, FL
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Clinical Trial Management of Boca Raton, Inc.
mi
from
Boca Raton, FL
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Pratt, KA
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Health Science Center
mi
from
Pratt, KA
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Boston, MA
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Beth Israel Deacon Medical Center
mi
from
Boston, MA
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Omaha, NE
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Heartland Clinical Research, Inc.
mi
from
Omaha, NE
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Margate, NJ
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
MBS Clinical Research, LLC
mi
from
Margate, NJ
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Bellbrook, OH
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Midwest Clinical Research
mi
from
Bellbrook, OH
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Hermitage, TN
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
Associates in Gastroenterology
mi
from
Hermitage, TN
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Lake Jackson, TX
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
R/D Clinical Research, Inc.
mi
from
Lake Jackson, TX
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Richmond, VA
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
National Clinical Research, Inc.
mi
from
Richmond, VA
Click here to add this to my saved trials
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Virginia Beach, VA
Preference of Tegaserod vs. PEG 3350 in Patients With Constipation
A Randomized, Open-label, Pilot Crossover Study to Assess the Patient Preference of Tegaserod Versus Polyethylene Glycol 3350 in Patients With Constipation
Status: Enrolling
Updated: 3/2/2016
East Coast Clinical Research
mi
from
Virginia Beach, VA
Click here to add this to my saved trials
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
North Little Rock, AZ
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status: Enrolling
Updated: 3/2/2016
Arkansas Gastroenterology, PA
mi
from
North Little Rock, AZ
Click here to add this to my saved trials
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Ann Arbor, MI
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status: Enrolling
Updated: 3/2/2016
University of Michigan Medical Center
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status: Enrolling
Updated:  3/2/2016
mi
from
Philadelphia, PA
Effect of Tegaserod on Orocecal Transit in Elderly Chronic Constipation Patients
The Effects of Tegaserod on Orocecal Transit in Elderly Patients With Chronic Constipation
Status: Enrolling
Updated: 3/2/2016
Temple University Hospital
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Anniston, AL
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 1827
mi
from
Anniston, AL
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Foley, AL
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 1047
mi
from
Foley, AL
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Phoenix, AZ
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site
mi
from
Phoenix, AZ
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Tucson, AZ
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative site 096
mi
from
Tucson, AZ
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
North Little Rock, AR
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 135
mi
from
North Little Rock, AR
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Anaheim, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 1822
mi
from
Anaheim, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Fountain Valley, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative site 028
mi
from
Fountain Valley, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Fresno, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative site 064
mi
from
Fresno, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Garden Grove, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site #021
mi
from
Garden Grove, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Gold River, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 3410
mi
from
Gold River, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Lincoln, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 1871
mi
from
Lincoln, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
North Hollywood, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 084
mi
from
North Hollywood, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Orange, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 009
mi
from
Orange, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Sacramento, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site
mi
from
Sacramento, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
San Diego, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 007
mi
from
San Diego, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Santa Ana, CA
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative Site 073
mi
from
Santa Ana, CA
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Colorado Springs, CO
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative site 077
mi
from
Colorado Springs, CO
Click here to add this to my saved trials
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated:  3/22/2016
mi
from
Colorado Springs, CO
Phase 2 Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered to Patients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
A Phase 2 Multicenter, Randomized, Double-Blind, Placebo-Controlled, Parallel Group Trial of Linaclotide Administered Orally for 8 Weeks to Adult Outpatients With Opioid-Induced Constipation Receiving Chronic Opioid Treatment for Non-Cancer Pain
Status: Enrolling
Updated: 3/22/2016
Forest Investigative site 077
mi
from
Colorado Springs, CO
Click here to add this to my saved trials